Zecotek News

heute kommt garantiert ein bv-push!

**************************************************

News from Canada NewsWire


Zecotek advances research initiatives to develop "PET - MRI" in a collaborative agreement with University of Washington - Offering the next generation in medical imaging
09:30 EDT Thursday, July 27, 2006



SINGAPORE, July 27 /CNW/ - Zecotek Medical Systems Singapore Pte Ltd, a division of Zecotek Medical Systems Inc., (TSX-Venture - ZMS; Frankfurt- W1I.F) today announced that it has entered into a Collaborative Research Agreement with the University of Washington. Jointly, the two parties will develop a proprietary PET-MRI detector as the core technology of a next generation medical imaging system.

"Zecotek's new crystal materials, photo-detectors and advanced optical components design are critical to a successful fusion of PET and MRI into one machine. The major barrier to a fusion of PET-MRI has been the strong magnetic fields of MRI which destroy the photo-detection capabilities of current PET" states Dr. Faouzi Zerrouk, Chairman and CEO of the Company "Zecotek has developed the technologies to overcome this barrier and will be working with UofW on a complete solution."

Dr. Zerrouk added; "We are very excited at having entered into this agreement with Prof. Lewellen and his team. Prof. Lewellen is considered a leading worldwide researcher in the field of high resolution PET system development and has established immense credibility with major medical OEMs. Prof. Lewellen and his team have acknowledged Zecotek's contribution to the project as the 'breakthrough technologies' needed for the successful development of a PET/MRI system, considered the next gold standard in Medical Imaging."


Company Roadmap: Moving up the Value Chain

------------------------------------------


The increasing demand for improved imaging tools in the early detection and treatment of disease is resulting in both a rapid growth in equipment sales and an evolution in imaging technologies. Medical device OEM's now offer an array of image detection devices to capture human anatomy (X-ray, Computed Tomography or CT, and Magnetic Resonance Imaging or MRI) and biological activity (the Positron Emission Tomography or PET scanner) in a global market estimated at US$10 billion annually. The fastest growth segment is the PET-CT scanner, a hybrid device that captures both anatomical abnormalities as well as biological activity at the molecular level. Currently the frontier in imaging for disease detection and treatment, PET-CT sales are expected to pass US$1 billion annually.

To date, the principal focus of the Company's Imaging Division has been the development of enabling technologies for the PET-CT devices of third party OEMs. These include the Company's LFS scintillation material as a performance upgrade to present PET-CT devices (marketed by Northrop Grumman under an exclusive 20 years licensing agreement), as well as other technologies in development, including new solid state photo-detectors and scintillation materials.

While these enabling technologies represent significant value and will continue to be an important source of the Company's revenue, to deliver increased value to shareholders the Company's roadmap includes selectively moving up the value chain with the development and commercialization of complete devices in its new 9000 square foot research and production facilities in Singapore. Combined PET/MRI/MRS systems offer unique capabilities in simultaneous imaging of anatomy and function. While the fusion of these technologies has previously been attempted, a completely integrated system has not yet been possible due to a number of issues, including the impact of the magnetic field of the MRI system on the PET detectors. The Company's proprietary technologies, described as "critical enabling technologies" by UofW group leader Dr. Tom Lewellen, will be key components to overcoming these issues and making a completely integrated system a reality.


The Alliance with the University of Washington

----------------------------------------------


The PET-MRI development project is a joint collaboration between Zecotek and the University of Washington, where the Agreement recognizes existing pre-agreement rights of the United States Government National Institute of Health in the pre-agreement intellectual property developed at the University. Each party will contribute proprietary intellectual property to the project. Under the Agreement, Zecotek will contribute the project's funding and the enabling technologies of scintillation crystals and solid state photo-detectors. The Company and the University will collaborate on systems and component designs as well as project management over the project's anticipated three year life. Among the Company's intellectual property contributions will be these new technologies in development, including its solid state photo-detectors and advanced scintillation materials. Part of the University's contribution is its extensive experience in PET detector and electronics design as well as system integration and image reconstruction algorithms and display/analysis. New designs developed at UofW will utilize Zecotek's unique crystal and solid-state photo-detectors as well as access to Zecotek's expertise in optical components design, along with advancements in the University's unique FireWire based data acquisition methodologies and image reconstruction algorithms for the new scanners. The sole rights to commercialization obtained under the Agreement with the UofW represent an important operational step toward the Company's goal of developing and commercializing a proprietary PET/MRI system.

The Agreement was signed by Zecotek Medical Systems Singapore Pte Ltd, a wholly-owned subsidiary of the Company. "By signing this Agreement, Zecotek will benefit from this union, considered one of the most prestigious and widely recognized imaging research teams in the world" added Dr. Zerrouk.


 

geht die party los? :)  

am heutigen, roten Tag.

saludos
a Petruss  

Sieht so aus als wenn hier die Sauerbierzeit vorbei ist. :) Bin froh am 9.11. noch eingestiegen zu sein. Die 1,60Cad (PP) sollte schnell genommen werden.  

das war gestern und auch bisher heute mein einziges Papier ohne Sauerbierzeit.Umso erfreulicher !!!!
Gruß  

Käuferseite ist 8mal höher als Verkäuferseite. Hat jemand einen Tipp wo man in das Orderbuch in Kanada schauen kann? Ähm Kostenlos. Ansonsten muss ich mir mal denn Service für 30 Dollar im Monat gönnen...  

Ist das geil. Die Käufer wollen große Stückzahlen kaufen ohne den Kurs groß hochzuziehen. Also gehen die Spielchen mit der 40k reinraus Order los. löl
Man nimmt was man bekommen kann. Jetzt liegen nur noch 1k im Ask. Der Kurs muss HOCh gehen. Wir schließen über 1,50cad schätz/tippe ich mal mutig.
10:40:05 V 1.46 +0.12 500 2  RBC 83  Research Cap K
          §10:40:05 V 1.46 +0.12 1,000 2  RBC 1  Anonymous K
          §10:33:35 V 1.46 +0.12 4,000 7  TD Sec 1  Anonymous K
          §10:32:16 V 1.46 +0.12 5,000 7  TD Sec 83  Research Cap K
          §10:32:16 V 1.46 +0.12 1,000 7  TD Sec 83  Research Cap K
          §10:30:44 V 1.46 +0.12 1,000 7  TD Sec 83  Research Cap K
          §10:30:10 V 1.46 +0.12 3,000 7  TD Sec 83  Research Cap K
          §10:22:47 V 1.48 +0.14 4,000 7  TD Sec 83  Research Cap K
          §10:20:55 V 1.48 +0.14 500 99  Jitney 83  Research Cap K
          §10:18:10 V 1.48 +0.14 10,000 99  Jitney 83  Research Cap K  

wenn alle Produkte so einschlagen wie alle erwarten,wo könnte dann der kurs der Aktie stehen? kann man das vorsichtig!!! abschätzen?  

Da müßtest Du schon ein Zeitfenster angeben... Schau Dir die Marktkapitalisierung an...
 

22 mio aktien...  so auf 1-2 Jahre. kann man die mit ner Firma wie z.B. Stratec vergleichen?  

Stratec kenne ich nicht und Vergleiche zu ziehen naja... Die Produkte sind gut der Preis ist sehr moderat und die Nachfrage groß. Und noch andere Sachen/Projekte (zb. 3D Display!) laufen noch nebenbei. Also ich sehe hier einen Verdoppler in denn nächsten Monaten.  

doch gut aus.  

jetzt ist es soweit. Canacord kauft heute die ersten Stücke!

          §09:30:20 V 1.50 +0.02 3,000 33  Canaccord 68  Leede K
          §09:30:20 V 1.50 +0.02 2,000 33  Canaccord 2  RBC K
          §09:30:01 V 1.50 +0.02 5,000 33  Canaccord 2  RBC K
          §09:30:01 V 1.50 +0.02 7,000 7  TD Sec 2  RBC K
          §09:30:01 V 1.50 +0.02 1,000 19  Desjardins 2  RBC K
          §09:30:01 V 1.50 +0.02 4,000 19  Desjardins 1  Anonymous K
          §09:30:01 V 1.50 +0.02 3,500 5  Penson 1  Anonymous K
          §09:30:01 V 1.50 +0.02 1,500 5  Penson 59  PI KL  

Von Freitag aus Stockhouse...

The good news continues - with Market Tech selling lasers for Zeco.

The company was mentioned in Canaccord's morning note last week as a Canadian Equity of Interest. It looks like the stock is on the radar screen but has yet to generate any buying from Canaccord.  

MACD kreuzt bullish
Aktie mit 3 Monatshoch
Kurs über EMA 100  

 

Zecotek Sapphire laser selected by IQP


2007-11-15 06:24 ET - News Release

Dr. A.F. Zerrouk reports

ZECOTEK'S NEW CW NARROW-BAND TI: SAPPHIRE LASER SELECTED BY UNIVERSITY OF WATERLOO

Zecotek Medical Systems Inc.'s CW Ti: Sapphire laser, model TIS-FD-08/A-scan-WV, has been selected by the Institute for Quantum Computing, University of Waterloo, Canada. The laser is the latest ultrawide tunable laser to be developed by Zecotek and will be used by the institute in the field of nano-optics (the investigation of single semiconductor quantum dots) and quantum computing.

"We are very pleased that the University of Waterloo's prestigious Institute for Quantum Computing has selected our latest CW Ti: Sapphire laser," said Dr. A.F. Zerrouk, chairman, president and chief executive officer of Zecotek. "Our new auto-scanned narrow band Ti: Sapphire laser is a valuable tool in this important area of research and is another example of Zecotek's strength in the innovation and commercialization of leading edge photonic technologies."


The remainder is available to Stockwatch subscribers.
If you would like to give the Stockwatch system a try, click here for a free 30 day trial subscription.  

Scheisse hört gar nicht auf zu steigen... :)  

boah  

... sieht so aus, als ob es jetzt Schmerzensgeld gibt! Seit 7. November steigt der Kurs und von mir aus kann's noch ein paar Tage so weiter gehen.
Cheers,
PaiMei  

warum fallen die jetzt so ???? innerhalb so kurzer Zeit (2h)  

ist doch normal,wer damit zufrieden ist,solls sein,ich bleibe drin  

 

Jetzt geht die Post ab. werde noch mal kräftig nachkaufen. Endlich mal eine Perle erwischt. Ich hoffe ihr macht das gleiche  

Obwohl pofühler unablässig am trommeln ist und täglich seine Blödspammails verschickt kackt der Kurs immer weiter ab.

Seine negativ Performance darf sich durchaus an Dummpush-Schmieder vom DIR messen ;-))))))))))))))))  

...........nur keiner schaut hin ;-))))))))))))))))))

Ueberschrift seiner heutigen Blödspammail

Sind wir des Wahnsinns knusprige Beute? echt zum rofl

...obschon ja genug Lemminge auf seinen Blödsinn hereingefallen sind ;-(((((((((